Hematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematologic NeoplasmsMyeloablative AgonistsBone Marrow TransplantationBone MarrowBone Marrow CellsWhole-Body IrradiationUnrelated DonorsGraft vs Tumor EffectTransplantation, AutologousTissue DonorsGraft vs Leukemia EffectHistocompatibility TestingVidarabineTransplantation ChimeraTreatment OutcomeLeukemia, Myeloid, AcuteHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationChimerismRecurrenceGraft SurvivalRetrospective StudiesStem Cell TransplantationLeukemiaHistocompatibilityBusulfanCord Blood Stem Cell TransplantationSiblingsDonor SelectionSurvival AnalysisMyelodysplastic SyndromesHLA AntigensMinor Histocompatibility AntigensRemission InductionImmunosuppressive AgentsSurvival RateBone and BonesHematologic DiseasesDisease-Free SurvivalAllograftsPrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseT-LymphocytesTime FactorsGraft RejectionHematopoiesisCyclosporineLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFollow-Up StudiesCombined Modality TherapyCell DifferentiationImmunosuppressionMycophenolic AcidMice, Inbred C57BLLymphoma, Non-HodgkinCyclophosphamideRisk FactorsAntigens, CD34Lymphoproliferative DisordersLiving DonorsLymphocyte DepletionTacrolimusLymphomaChronic DiseaseCell TransplantationSalvage TherapyFetal BloodColony-Forming Units AssayAge FactorsKidney TransplantationFlow CytometryPrognosisTransplantation ImmunologyAntineoplastic AgentsBone Marrow DiseasesMultiple MyelomaAnemia, AplasticCells, CulturedCell LineageMesenchymal Stem Cell TransplantationCohort StudiesBone RemodelingRadiation ChimeraCytomegalovirus InfectionsMesenchymal Stromal CellsMice, Inbred BALB CAntigens, CDBone Marrow ExaminationTransplantationCD8-Positive T-LymphocytesLymphopoiesisFetusHeart TransplantationBone Marrow NeoplasmsStromal Cells